Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Depreciation & Amortization (CF) (2019 - 2024)

Avai Bio's Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $47267.0 for Q1 2024.

  • For Q1 2024, Depreciation & Amortization (CF) rose 1135.74% year-over-year to $47267.0; the TTM value through Mar 2024 reached $76953.0, up 228.62%, while the annual FY2025 figure was $74320.0, 3.42% down from the prior year.
  • Depreciation & Amortization (CF) for Q1 2024 was $47267.0 at Avai Bio, up from $10268.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $47267.0 in Q1 2024 and bottomed at -$55088.0 in Q1 2020.
  • The 4-year median for Depreciation & Amortization (CF) is $10292.5 (2023), against an average of $7123.6.
  • The largest annual shift saw Depreciation & Amortization (CF) tumbled 2644.48% in 2020 before it soared 1135.74% in 2024.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $14378.0 in 2020, then crashed by 73.4% to $3825.0 in 2022, then surged by 168.44% to $10268.0 in 2023, then surged by 360.33% to $47267.0 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Depreciation & Amortization (CF) are $47267.0 (Q1 2024), $10268.0 (Q4 2023), and $10317.0 (Q3 2023).